US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 31.370
  • -0.280-0.88%
Close Mar 28 16:00 ET
  • 31.370
  • 0.0000.00%
Post 20:01 ET
13.59BMarket Cap16.42P/E (TTM)

Royalty Pharma Key Stats

Royalty Pharma Q4 2024 Earnings Date

Currency:USDFeb 11, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
743.60M
593.64M
-149.96M
Miss Est.
+24.77%
-0.41%
-20.17%
EPS
0.25
0.35
+0.10
Beat Est.
-77.27%
-67.90%
+41.24%
Strong Buy

Mar 29, 2025

Royalty Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 657.801M--
--2025/Q1-- / 724.685M--
Feb 11, 20252024/Q4594.000M / 743.604M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 657.801M--
--2025/Q1-- / 724.685M--
Feb 11, 20252024/Q4594.000M / 743.604M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--

Unlock Free Earnings Estimates

Royalty Pharma Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More